Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4823 |  BGMS Bio Green Med Solution, Inc. - Common Stock | 0.82 USD | -3.53% | -6.82% | -4.65% | -82.66% | 5.43 M USD | ||
| 4833 |  CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 USD | +14.74% | +9.67% | +17.11% | +68.94% | 5.08 M USD | ||
| 4837 |  XBIO Xenetic Biosciences, Inc. - Common Stock | 2.12 USD | -4.07% | -7.83% | -48.92% | -75.60% | 4.97 M USD | ||
| 4838 |  LIMN Liminatus Pharma, Inc. - Class A Common Stock | 3.69 USD | -4.65% | -1.60% | +2.50% | +136.54% | 4.96 M USD | ||
| 4845 |  NCNA NuCana plc - American Depositary Shares | 1.13 USD | -0.88% | -5.83% | -19.29% | -47.44% | 4.70 M USD | ||
| 4848 |  XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 1.98 USD | 0.00% | -8.76% | -18.85% | +120.00% | 4.68 M USD | ||
| 4857 |  ENLV Enlivex Ltd. - Ordinary Shares | 0.28 USD | -9.68% | -33.33% | -73.08% | -76.07% | 4.43 M USD | ||
| 4863 |  DRMA Dermata Therapeutics, Inc. - Common Stock | 1.07 USD | -4.46% | -7.76% | -13.71% | -25.17% | 4.30 M USD | ||
| 4864 |  PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.40 USD | -2.44% | -2.44% | -16.67% | -60.00% | 4.29 M USD | ||
| 4873 |  ERNA Ernexa Therapeutics Inc. - Common Stock | 2.49 USD | +4.18% | -17.00% | -40.71% | +611.43% | 4.06 M USD | ||
| 4878 |  ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.18 USD | +6.71% | +4.26% | -13.35% | -63.78% | 3.92 M USD | ||
| 4886 |  PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.35 USD | -4.93% | -21.97% | -35.10% | -39.19% | 3.77 M USD | ||
| 4891 |  GRI GRI Bio, Inc. - Common Stock | 1.68 USD | -9.19% | -16.00% | -14.29% | -36.60% | 3.67 M USD | ||
| 4897 |  EVGN Evogene Ltd. - Ordinary Shares | 0.40 USD | -2.44% | -2.44% | -20.00% | -69.92% | 3.49 M USD | ||
| 4899 |  SXTP 60 Degrees Pharmaceuticals, Inc. - Common Stock | 0.97 USD | -11.82% | -24.22% | +3.19% | -40.85% | 3.41 M USD | ||
| 4901 |  CVKD Cadrenal Therapeutics, Inc. - Common Stock | 0.93 USD | -4.12% | -5.10% | -23.77% | -83.15% | 3.32 M USD | ||
| 4905 |  APVO Aptevo Therapeutics Inc. - Common Stock | 1.80 USD | -2.17% | 0.00% | -4.76% | -73.33% | 3.24 M USD | ||
| 4909 |  REVB Revelation Biosciences, Inc. - Common Stock | 0.78 USD | -6.02% | -3.70% | -23.53% | -43.48% | 3.11 M USD | ||
| 4912 |  MLEC Moolec Science SA - Ordinary Shares | 4.19 USD | -12.89% | -13.61% | -38.38% | +398.81% | 3.04 M USD | ||
| 4918 |  MBIO Mustang Bio, Inc. - Common Stock | 0.41 USD | -8.89% | -12.77% | -25.45% | -52.87% | 2.97 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |